Long-Term Effects of Apixaban Confirmed in the Open-Label Extension of AVERROES Trial

被引：0
|
作者：
Chao, Tze-Fan [1 ,2 ,3 ]
Potpara, Tatjana S. [4 ,5 ]
机构：
[1] Taipei Vet Gen Hosp, Div Cardiol, Dept Med, Taipei, Taiwan
[2] Natl Yang Ming Univ, Inst Clin Med, Taipei, Taiwan
[3] Natl Yang Ming Univ, Cardiovasc Res Ctr, Taipei, Taiwan
[4] Univ Belgrade, Sch Med, Belgrade, Serbia
[5] Clin Ctr Serbia, Cardiol Clin, Belgrade, Serbia
来源：
THROMBOSIS AND HAEMOSTASIS | 2021年 / 121卷 / 04期
关键词：
ATRIAL-FIBRILLATION; WARFARIN; ANTICOAGULATION; DABIGATRAN; TRANSITION; STROKE; DRUG; END;
D O I：
10.1055/a-1367-0184
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：405 / 407
页数：3
相关论文
共 50 条
  • [41] Long-term treatment of psychotic patients with risperidone. An open-label multicentre trial
    Kocmur, M
    Tavcar, R
    Dernovsek, MZ
    SCHIZOPHRENIA RESEARCH, 2000, 41 (01) : 199 - 199
  • [42] Long-term use of rivastigmine in patients with dementia with Lewy bodies: An open-label trial
    Grace, J
    Daniel, S
    Stevens, T
    Shankar, KK
    Walker, Z
    Byrne, EJ
    Butler, S
    Wilkinson, D
    Woolford, J
    Waite, J
    McKeith, IG
    INTERNATIONAL PSYCHOGERIATRICS, 2001, 13 (02) : 199 - 205
  • [43] Long-term treatment of patients with idiopathic pulmonary fibrosis with nintedanib: results from the TOMORROW trial and its open-label extension
    Richeldi, Luca
    Kreuter, Michael
    Selman, Moises
    Crestani, Bruno
    Kirsten, Anne-Marie
    Wuyts, Wim A.
    Xu, Zuojun
    Bernois, Katell
    Stowasser, Susanne
    Quaresma, Manuel
    Costabel, Ulrich
    THORAX, 2018, 73 (06) : 581 - 583
  • [44] An Interim Analysis Of Long-Term Outcomes In Patients Treated With Bosentan In The Double-Blind Or Open-Label Extension To The Early Trial
    Simonneau, G.
    Galie, N.
    Hoeper, M. M.
    Kusic-Pajic, A.
    Morganti, A.
    Rubin, L. J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
  • [45] A randomized, open-label clinical trial comparing the long-term effects of miltefosine and meglumine antimoniate for mucosal leishmaniasis
    Ribeiro Sampaio, Raimunda Nonata
    Fontenele e Silva, Juliana Saboia
    Ribeiro de Paula, Carmen Dea
    Porte, Claudia
    Carneiro da Motta, Jorgeth de Oliveira
    de Araujo Pereira, Ledice Inacia
    Martins, Sofia Sates
    Barroso, Daniel Holanda
    Magalhaes Freire, Gustavo Subtil
    Gomes, Ciro Martins
    REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL, 2019, 52
  • [46] LONG-TERM EFFECTS OF NALBUPHINE ER TABLETS IN HEMODIALYSIS PATIENTS WITH UREMIC PRURITUS: A MULTICENTER OPEN-LABEL TRIAL
    Kumar, Jayant
    Crawford, Paul
    Mathur, Vandana
    Sciascia, Thomas
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2016, 67 (05) : A64 - A64
  • [47] Long-Term Safety and Efficacy of Add-on Cannabidiol (CBD) Treatment in Patients with Dravet Syndrome in an open-label, Extension Trial
    Halford, Jonathan
    Scheffer, Ingrid
    Nabbout, Rima
    Sanchez-Carpintero, Rocio
    Malawsky, Yael Shiloh
    Wong, Matthew
    Checketts, Daniel
    VanLandingham, Kevan
    NEUROLOGY, 2019, 92 (15)
  • [48] Effects of long-term prophylaxis with subcutaneous C1 inhibitor in special patient populations: Findings from the COMPACT open-label extension trial
    Levy, D. S.
    Craig, T.
    Longhurst, H.
    Cicardi, M.
    Chiao, J.
    Feuersenger, H.
    Prusty, S.
    Pragst, I
    ALLERGY, 2019, 74 : 10 - 10
  • [49] Open-label long-term use of divalproex sodium in headache
    Diamond, S
    Freitag, FG
    Diamond, ML
    Urban, GJ
    Pepper, BJ
    Bhambhavani, D
    HEADACHE QUARTERLY-CURRENT TREATMENT AND RESEARCH, 1997, 8 (01): : 42 - 44
  • [50] A long-term, open-label study of valbenazine for tardive dyskinesia
    Lindenmayer, Jean-Pierre
    Verghese, Cherian
    Marder, Stephen R.
    Burke, Joshua
    Jimenez, Roland
    Siegert, Scott
    Liang, Grace S.
    O'Brien, Christopher F.
    CNS SPECTRUMS, 2021, 26 (04) : 345 - 353
12345